News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
09-Dec-2005 - The U.S. Department of Agriculture has awarded a $2 million grant to Cornell University, Colorado State University and the University of Nebraska to examine ways to control the deadly foodborne pathogen Listeria monocytogenes. Colorado State will be the lead institution on this project, and ...
09-Dec-2005 - ID Biomedical Corporation announced that the British Columbia Supreme Court has approved the proposed acquisition of ID Biomedical by GlaxoSmithKline plc and GlaxoSmithKline Inc., including a change to the terms described in ID Biomedical's management proxy circular (the "Circular") dated October ...
08-Dec-2005 - Novartis announced that it has received US regulatory approval to acquire the remaining 58% stake in the US pharmaceutical company Chiron Corporation that it does not currently own. Novartis reaffirms that it expects to complete the acquisition of Chiron in the first half of 2006, subject to ...
08-Dec-2005 - Galapagos announced that its services division BioFocus has extended its drug discovery collaboration with Amgen for biology, computational/medicinal chemistry services and supply of biologically-directed library compounds for Amgen's ion channel lead discovery programs throughout 2006. This ...
08-Dec-2005 - Arrayjet announced that a European patent had been granted for 'Fabrication of microarrays by inkjet printheads'. Used inside the company's Aj100 and Aj120 microarrayers this technology enables samples to be picked up from 96 or 384 well plates and then printed in arrays ranging from a few spots ...
08-Dec-2005 - ProtoKinetix, Inc.'s president and CEO, Dr. John Todd, announced that Cabinet Moutard, patent specialists in France, have completed filing the AAGP(TM) patents. This extremely detailed filing is a world wide patent of the anti-aging glycoprotein family of molecules. The patents include all ...
08-Dec-2005 - Immune Targeting Systems (ITS) announced it has developed the world's first fully synthetic Influenza vaccine which targets all Human, Bird and Swine Influenza strains. By targeting highly conserved components within all these viral strains it means that no matter what bird flu virus ultimately ...
07-Dec-2005 - PhotoCure ASA is, together with its subsidiary PCI Biotech AS, developing a proprietary technology for site-specific drug delivery called photochemical internalisation (PCI). The PCI technology uses light to activate drug delivery and can be used to enhance the effect of drugs by targeted ...
07-Dec-2005 - Vertex Pharmaceuticals Incorporated announced the initiation of a Phase II clinical trial for VX-950, an investigational oral hepatitis C virus (HCV) protease inhibitor for the treatment of HCV infection. The 28-day study will evaluate the safety, tolerability and pharmacodynamics of VX-950 when ...
07-Dec-2005 - CEL-SCI CORPORATION has signed a Cooperative Agreement with the National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health of the U.S. government, to test CEL-SCI's patented anti-infective drug CEL-1000 against the avian flu virus H5N1 in ...
© 1997-2024 LUMITOS AG, All rights reserved